KSHV
Showing 1 - 25 of 44
KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by
Not yet recruiting
- KSHV Inflammatory Cytokine Syndrome (KICS)
- Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 2, 2023
s From HIV Infection, KSHV Infection, Viral-Related
Recruiting
- HIV
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,
Active, not recruiting
- Lymphoproliferative Disorder
- +3 more
- Etoposide
- +13 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Viral Associated Malignancies, Kaposi Sarcoma, EBV/KSHV-associated Lymphomas Trial run by the NCI (Pomalidomide, Nivolumab)
Recruiting
- Viral Associated Malignancies
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 20, 2022
Castleman Disease, Multicentric Castleman Disease, Giant Lymph Node Hyperplasia Trial run by the NCI (Zidovudine, Tocilizumab,
Completed
- Castleman Disease
- +2 more
- Zidovudine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 8, 2020
Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,
Recruiting
- Burkitt Lymphoma
- +2 more
- Rituximab and Hyaluronidase Human
- +8 more
-
Kampala, UgandaUCI-Fred Hutch Cancer Centre
Mar 9, 2022
Kaposi Sarcoma, Skin Trial in Los Angeles, Saint Louis (Ixazomib Citrate, Quality-of-Life Assessment, Questionnaire
Suspended
- Kaposi Sarcoma
- Skin
- Ixazomib Citrate
- +2 more
-
San Diego, California
- +1 more
Jan 30, 2023
Kaposi's Sarcoma, HHV-8, KSHV Trial run by the NCI (BAY 43-9006)
Terminated
- Kaposi's Sarcoma
- +2 more
- BAY 43-9006
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019
Risk Factors for Non-HIV-Related Kaposi s Sarcoma
Completed
- Kaposi's Sarcoma
-
Palermo, ItalyUniversita Degli Studi Di Palermo
Mar 11, 2021
Lymphoma, Primary Effusion Trial run by the National Cancer Institute (NCI) (Daratumumab SC)
Not yet recruiting
- Lymphoma, Primary Effusion
- Daratumumab SC
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 23, 2023
Kaposi Sarcoma Trial run by the NCI (Abemaciclib)
Recruiting
- Kaposi Sarcoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Advanced Malignant Solid Tumor, Anal Carcinoma, HIV Infection Trial in Australia, United States (Ipilimumab, Nivolumab)
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Ipilimumab
- Nivolumab
-
La Jolla, California
- +34 more
Nov 29, 2022
AIDS-Related Non-Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 Trial in United
Recruiting
- AIDS-Related Non-Hodgkin Lymphoma
- +29 more
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Birmingham, Alabama
- +12 more
Aug 4, 2022
HHV8 and Solid Organ Transplantation
Recruiting
- HHV8
- +7 more
- Diagnostic test for HHV8 exposure
-
Milan, ItalyFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Oct 4, 2021
Development of Serologic Assays for Human Herpes Virus-8
Completed
- Kaposi Sarcoma
- HIV Infection
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 10, 2020
Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease, Primary Effusion Lymphoma Trial (Pomalidomide,
Withdrawn
- Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease
- Primary Effusion Lymphoma
- Pomalidomide
- +6 more
- (no location specified)
Aug 29, 2018
Subsets of HIV-associated Kaposi Sarcoma in Malawi
Completed
- Kaposi Sarcoma
- HIV
-
Lilongwe, Malawi
- +1 more
Dec 15, 2020
AIDS-Related Kaposi Sarcoma, Recurrent Kaposi Sarcoma Trial in United States (Lenalidomide)
Completed
- AIDS-Related Kaposi Sarcoma
- Recurrent Kaposi Sarcoma
-
Los Angeles, California
- +12 more
Jan 13, 2022
Hodgkin Lymphoma, Non Hodgkin Lymphoma, Kaposi's Sarcoma Trial in Baltimore (FIAU-PET-CT-2, FIAU-PET-CT-4)
Completed
- Hodgkin Lymphoma
- +4 more
- FIAU-PET-CT-2
- FIAU-PET-CT-4
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Sep 13, 2018
HIV-1 Infection Trial in Worldwide (Etoposide (ET), Bleomycin and Vincristine (BV), Paclitaxel (PTX))
Completed
- HIV-1 Infection
- Etoposide (ET)
- +3 more
-
Rio de Janeiro, Brazil
- +10 more
Sep 24, 2021
Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
Completed
- HIV Seropositivity
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 11, 2019
Kaposi's Sarcoma Trial in San Francisco (Maraviroc)
Completed
- Kaposi's Sarcoma
-
San Francisco, CaliforniaSan Francisco General Hospital, Clinical Trials Unit
Mar 3, 2021
Kaposi Sarcoma, HIV/AIDS, Immunosuppression Trial in San Francisco (Intra-lesional injection of nivolumab)
Completed
- Kaposi Sarcoma
- +2 more
- Intra-lesional injection of nivolumab
-
San Francisco, CaliforniaZuckerberg San Francisco General Hospital
Oct 7, 2021